Fundz

LSL Pharma Group

Boucherville, Canada · Biotechnology, Dietary Supplements, Health Care

LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company specializing in the development, manufacturing and commercialization of high-quality sterile ophthalmic pharmaceutical products, as well as pharmaceutical, cosmetic and natural health products in solid, semi-solid and liquid dosage forms. . Leveraging its technical expertise, certified facilities, and experienced team, LSL Pharm

Key facts

Headquarters
Boucherville, Canada
Employees
18
Industries
Biotechnology, Dietary Supplements, Health Care
Status
Private
Website
groupelslpharma.com
LinkedIn
Company page

Recent activity at LSL Pharma Group

LSL Pharma Group funding history

DateRoundAmount
Mar 2024Post-IPO Equity$6.4M

Leadership

  • Golnaz Kalantar, Vice President-PMO, New Product Development
  • François Roberge, Chief Executive Officer
  • Luc Mainville, Chief Financial Officer
  • Francis Chenard, Vice Président Principal et Chef des Operations (COO)
  • Francis Chenard, Chief Operating Officer
  • Luc Mainville, Chief Financial Officer

Verified email and direct lines for LSL Pharma Group’s decision-makers are on Fundz. See plans

LSL Pharma Group in the news

Companies similar to LSL Pharma Group

About LSL Pharma Group: questions and answers

What does LSL Pharma Group do?

LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company specializing in the development, manufacturing and commercialization of high-quality sterile ophthalmic pharmaceutical products, as well as pharmaceutical, cosmetic and natural health products in solid, semi-solid and liquid dosage forms. . Leveraging its technical expertise, certified facilities, and experienced team, LSL Pharm

Where is LSL Pharma Group headquartered?

LSL Pharma Group is headquartered in Boucherville, Canada.

How many employees does LSL Pharma Group have?

LSL Pharma Group has about 18 employees.

Has LSL Pharma Group raised funding?

Yes. Fundz has recorded 1 funding event for LSL Pharma Group. The most recent, Post-IPO Equity of $6.4M, was in Mar 2024.

Who leads LSL Pharma Group?

Golnaz Kalantar is a Vice President-PMO, New Product Development at LSL Pharma Group.

What is the latest news on LSL Pharma Group?

On Sep 10, 2026, LSL Pharma Begins Search for New Chief Financial Officer

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches LSL Pharma Group across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.